R. Basser

1.0k total citations
31 papers, 731 citations indexed

About

R. Basser is a scholar working on Oncology, Hematology and Cancer Research. According to data from OpenAlex, R. Basser has authored 31 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 9 papers in Hematology and 7 papers in Cancer Research. Recurrent topics in R. Basser's work include Cancer Treatment and Pharmacology (9 papers), Neutropenia and Cancer Infections (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). R. Basser is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Neutropenia and Cancer Infections (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). R. Basser collaborates with scholars based in Australia, United States and New Zealand. R. Basser's co-authors include Mark Rosenthal, Danny Rischin, Herbert I. Hurwitz, Richard de Boer, Scott N. Holden, Alan Barge, Catherine Wheeler, Sabine Eckhardt, C. Glenn Begley and Jonathan Cebon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cochrane Database of Systematic Reviews.

In The Last Decade

R. Basser

30 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Basser Australia 15 397 199 195 179 115 31 731
A. Van Oosterom Belgium 11 268 0.7× 228 1.1× 75 0.4× 209 1.2× 124 1.1× 28 572
Philippe Montcuquet France 16 581 1.5× 247 1.2× 71 0.4× 332 1.9× 248 2.2× 38 919
L. Leong United States 16 648 1.6× 199 1.0× 100 0.5× 241 1.3× 143 1.2× 41 1.0k
A. McDonald United Kingdom 14 409 1.0× 210 1.1× 118 0.6× 203 1.1× 127 1.1× 19 721
Roel J.W. van Kampen Netherlands 13 562 1.4× 118 0.6× 149 0.8× 283 1.6× 261 2.3× 18 891
J J Costanzi United States 20 641 1.6× 295 1.5× 187 1.0× 283 1.6× 272 2.4× 36 1.2k
Hazem El‐Osta United States 16 434 1.1× 262 1.3× 52 0.3× 234 1.3× 109 0.9× 35 893
Vito Spataro Switzerland 13 482 1.2× 370 1.9× 65 0.3× 156 0.9× 114 1.0× 26 1.0k
J. Wendall Goodwin United States 16 522 1.3× 186 0.9× 39 0.2× 334 1.9× 102 0.9× 34 1.0k
John Frye United States 10 286 0.7× 222 1.1× 33 0.2× 172 1.0× 91 0.8× 24 754

Countries citing papers authored by R. Basser

Since Specialization
Citations

This map shows the geographic impact of R. Basser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Basser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Basser more than expected).

Fields of papers citing papers by R. Basser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Basser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Basser. The network helps show where R. Basser may publish in the future.

Co-authorship network of co-authors of R. Basser

This figure shows the co-authorship network connecting the top 25 collaborators of R. Basser. A scholar is included among the top collaborators of R. Basser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Basser. R. Basser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Basser, R., et al.. (2025). A 69-Year-Old Woman with an Occipital Giant Proliferating Trichilemmal (Pilar) Cyst Treated with Surgical Resection. American Journal of Case Reports. 26. e947743–e947743.
2.
3.
Leuven, Sander I. van, Rakesh S. Birjmohun, Remco Franssen, et al.. (2008). ApoAI‐phosphatidylcholine infusion neutralizes the atherothrombotic effects of C‐reactive protein in humans. Journal of Thrombosis and Haemostasis. 7(2). 347–354. 15 indexed citations
4.
Bernhard, Jürg, David Zahrieh, Giovanni Martinelli, et al.. (2007). Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. British Journal of Cancer. 98(1). 25–33. 15 indexed citations
5.
Anderson, J., Jennifer Hoy, Richard J. Hillman, et al.. (2007). Abnormal anal cytology in high-risk human papilloma virus infection in HIV-infected Australians. Sexually Transmitted Infections. 84(2). 94–96. 18 indexed citations
6.
Holden, Scott N., Sabine Eckhardt, R. Basser, et al.. (2005). Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors. Annals of Oncology. 16(8). 1391–1397. 247 indexed citations
7.
Farquhar, Cindy, R. Basser, Jane Marjoribanks, & Anne Lethaby. (2003). High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. Cochrane Database of Systematic Reviews. CD003139–CD003139. 15 indexed citations
8.
Basser, R., Andrew Grigg, Jonathan Cebon, et al.. (2003). A phase I dose-escalation study of docetaxel with granulocyte colony-stimulating factor support in patients with solid tumours. Annals of Oncology. 14(5). 788–794. 5 indexed citations
9.
Rosenthal, Mark, Danny Rischin, Grant A. McArthur, et al.. (2002). Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia. Annals of Oncology. 13(5). 770–776. 47 indexed citations
10.
Farquhar, Cindy, R. Basser, Sarah Hetrick, Anne Lethaby, & Jane Marjoribanks. (2002). High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer. Cochrane Database of Systematic Reviews. CD003142–CD003142. 18 indexed citations
11.
12.
Roberts, Marion M., Bernadette Swart, Paul J. Simmons, et al.. (1999). Prolonged release and c‐kit expression of haemopoietic precursor cells mobilized by stem cell factor and granulocyte colony stimulating factor. British Journal of Haematology. 104(4). 778–784. 12 indexed citations
13.
Basser, R., et al.. (1999). Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer. Annals of Oncology. 10(1). 53–58. 23 indexed citations
14.
Thomas, David M., JF Seymour, Jeff Szer, et al.. (1998). Progress in management of acute myeloid leukaemia (AML) in Australia since 1980: a single institution retrospective study. Australian and New Zealand Journal of Medicine. 28(2). 190–196. 1 indexed citations
15.
Basser, R., Dermot Maher, Denis J. Morgan, et al.. (1998). Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer.. Journal of Clinical Oncology. 16(6). 2181–2187. 1 indexed citations
16.
Goss, Glenwood, Jeff Szer, R. Basser, R. M. Fox, & Andrew Grigg. (1997). Multiple cycles of aggressive chemotherapy prior to autologous peripheral stem cell transplantation for lymphoma. Australian and New Zealand Journal of Medicine. 27(3). 323–329. 4 indexed citations
17.
Basser, R., et al.. (1996). The Role of Platelet Growth Factors in Cancer Therapy. Stem Cells. 14(S1). 274–280. 8 indexed citations
18.
Gibbs, Peter, et al.. (1995). Thrombocytopenia: New approaches to resolve a major problem in chemotherapy. 8(5). 255–259. 3 indexed citations
19.
Basser, R., et al.. (1994). CONSERVATIVE MANAGEMENT OF SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL. Australian and New Zealand Journal of Surgery. 64(11). 754–758. 8 indexed citations
20.
Basser, R., Graham J. Lieschke, William Sheridan, R. M. Fox, & M. D. Green. (1991). Recombinant alpha‐2b interferon in patients with malignant carcinoid tumour. Australian and New Zealand Journal of Medicine. 21(6). 875–878. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Van Oosterom Breakdown of academic impact, for papers by Philippe Montcuquet Breakdown of academic impact, for papers by L. Leong Breakdown of academic impact, for papers by A. McDonald Breakdown of academic impact, for papers by Roel J.W. van Kampen Breakdown of academic impact, for papers by J J Costanzi Breakdown of academic impact, for papers by Hazem El‐Osta Breakdown of academic impact, for papers by Vito Spataro Breakdown of academic impact, for papers by J. Wendall Goodwin Breakdown of academic impact, for papers by John Frye
Rankless by CCL
2026